Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 5/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15726531 | 1.00 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL3797840 | 1.00 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL31481564 | 1.00 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL14085627 | 1.00 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL15731929 | 1.00 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL31111470 | 1.00 | SMPD1 (0.53) | SMPD1 | |
| SCHEMBL28591699 | 0.98 | SMPD1 (0.51) | SMPD1 | |
| SCHEMBL7997525 | 0.94 | SLC6A5 (0.50) | SMPD1 | |
| SCHEMBL38650614 | 0.92 | SMPD1 (0.56) | SMPD1 | |
| SCHEMBL31174418 | 0.92 | SMPD1 (0.47) | SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741411-A2 | OLIGONUCLEOTIDE PRODUCTION METHOD, AND NUCLEOSIDE, NUCLEOTIDE, OR OLIGONUCLEOTIDE | AJINOMOTO CO., INC. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-12559517-B2 | Oligonucleotide manufacturing method | AJINOMOTO CO., INC. (JP) | 2026-02-24 | — | — | US | disclosed |
| EP-3676265-B1 | METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-08-20 | — | — | EP | disclosed |
| US-20250019360-A1 | METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-01-16 | — | — | US | disclosed |
| CN-113717239-B | Precipitation accelerator and precipitation method using the same | 味之素株式会社 | 2024-12-24 | — | — | CN | disclosed |
| US-12122759-B2 | Method for the synthesis of cyclic depsipeptides | ELANCO ANIMAL HEALTH GMBH (DE) | 2024-10-22 | — | — | US | disclosed |
| EP-4332111-A1 | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND | Nippon Shinyaku Co., Ltd. (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-116063365-A | Method for preparing oligonucleotide and nucleoside, nucleotide or oligonucleotide | 味之素株式会社 | 2023-05-05 | — | — | CN | disclosed |
| EP-3263579-B1 | PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED | AJINOMOTO KK (JP) | 2022-11-30 | — | — | EP | disclosed |
| EP-4049991-A1 | PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED | AJINOMOTO CO., INC. (JP) | 2022-08-31 | — | — | EP | disclosed |
| EP-3263579-A1 | PRECIPITATION ACCELERATOR AND PRECIPITATION METHOD IN WHICH SAME IS USED | AJINOMOTO CO., INC. (JP) | 2018-01-03 | — | — | EP | disclosed |
| US-20170320904-A1 | PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED | AJINOMOTO CO., INC. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170320904-A1 | PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED | AJINOMOTO CO., INC. (JP) | 2017-11-09 | — | — | US | disclosed |
| WO-2017161293-A1 | POLYCATENAR LIGANDS AND HYBRID NANOPARTICLES MADE THEREFROM | RHODIA OPERATIONS (FR) | 2017-09-21 | — | — | WO | disclosed |
| US-9206230-B2 | Benzylic compound | AJINOMOTO CO., INC. (JP) | 2015-12-08 | — | — | US | disclosed |
| US-20140371424-A1 | BENZYLIC COMPOUND | AJINOMOTO CO., INC. (JP) | 2014-12-18 | — | — | US | disclosed |
| US-8859732-B2 | Benzylic compound | AJINOMOTO CO., INC. (JP) | 2014-10-14 | — | — | US | disclosed |
| EP-2518041-A1 | BENZYL COMPOUND | Ajinomoto Co., Inc. (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-20110160433-A1 | BENZYLIC COMPOUND | AJINOMOTO CO., INC. (JP) | 2011-06-30 | — | — | US | disclosed |
| JP-2000044493-A | PROTECTING GROUP FOR SYNTHESIZING COMPOUND LIBRARY | ASAHI CHEM IND CO LTD | 2000-02-15 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160433-A1 | BENZYLIC COMPOUND | VIP, NGLY1, FURIN | SMPD1 3227/4885 |
| US-20140371424-A1 | BENZYLIC COMPOUND | VIP, NGLY1, FURIN | SMPD1 3227/4885 |
| US-20170320904-A1 | PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED | SP1, MED25, CTCF | SMPD1 4221/4885 |
| US-12122759-B2 | Method for the synthesis of cyclic depsipeptides | DNPEP, NPEPPS, PREP | SMPD1 1100/4885 |
| US-20250019360-A1 | METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES | DNPEP, NPEPPS, PREP | SMPD1 1100/4885 |
| US-12559517-B2 | Oligonucleotide manufacturing method | POLL, IGF2BP1, POLI | SMPD1 1495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.